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Abstract 
Bioceramics for bone tissue regeneration, local drug delivery and nanomedicine, are 
receiving growing attention by the biomaterials scientific community. The design of 
bioceramics with improved surface properties able to overcome clinical issues is a great 
scientific challenge. Zwitterionization of surfaces has arisen as a powerful alternative in 
the design of biocompatible bioceramics capable to inhibit bacterial and non-specific 
protein adsorption, which opens up new insights into the biomedical applications of 
these materials. This manuscript reviews the different approaches reported up to date for 
the synthesis and characterization of zwitterionic bioceramics with potential clinical 
applications.  
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1. Introduction 
Bioceramics have experienced great development in the last 50 years [1]. Their 
biomedical applications include bone tissue regeneration, local drug delivery and 
nanomedicine, which are receiving increasing attention by the biomaterials scientific 
community [2-6]. The custom-made design of bioceramics attending to their envisioned 
clinical application constitutes a great scientific challenge. Bioceramics for bone tissue 
regeneration and local drug delivery must fulfill some specific requirements such as 
allowing adequate biocompatibility and cell response. Infection constitutes one of the 
major concerns in these biomedical fields, with high morbidity and costs to the national 
healthcare systems [7]. The design and development of bioceramic surfaces capable to 
inhibit bacterial adhesion meanwhile allowing osteoblast cells colonization would be 
and added value to achieve better clinical outcomes [2]. 
On the other hand, bioceramic nanoparticles (NPs) provide many opportunities in the 
nanomedicine landscape, such as therapy and diagnosis [6].
  
One of the main drawbacks 
that NPs have to face once they are in contact with physiological fluids is their trend to 
associate to plasma proteins, forming a “protein corona” that may lead to their clearance 
from the bloodstream or interfere in their final fate. In this sense, the design of 
bioceramic NPs with non-fouling properties would constitute a step forward in their 
potential applications. One of the most widely used strategies consists in grafting 
polyethylenglycol (PEG) onto the surface of these NPs. Nonetheless, this method 
usually provokes an increase in the overall hydrodynamic NP size, which could alter the 
in vivo final destination of these nanosystems [8]. 
Zwitterionization has emerged as a powerful tool to provide bioceramic surfaces of 
antibacterial adhesion and resistance to non-specific protein adsorption capabilities. 
Zwitterionic materials are characterized by owning equal number of both positively and 
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negatively charged groups onto their surface thus maintaining overall electrical 
neutrality [9]. The non-fouling capability of zwitterionic materials is related to a 
hydration layer onto the surface, since a tightly bound water layer forms a physical and 
energetic barrier that prevents bacterial adhesion and non-specific protein adsorption. It 
is possible to optimize functionalization methods to graft both positively and negatively 
charged moieties onto the bioceramic surfaces. Thus, different zwitterionization 
approaches have been developed so far to prepare advanced zwitterionic bioceramics. 
Herein the main strategies reported to date for the zwitterionization of bioceramics 
are overviewed. An overall discussion of the different mechanisms that govern the 
colonization of biomaterial surfaces by cells and bacteria is also presented. In addition, 
the diverse characterization techniques to evaluate the zwitterionic nature of these 
materials are described. Finally, the different biomedical applications of zwitterionic 
bioceramics, focusing on bone tissue regeneration, local drug delivery and 
nanomedicine are reviewed.    
 
2. Interactions between Bioceramic Surfaces and Biological Milieu 
Recently, zwitterionization of bioceramics has emerged as a groundbreaking strategy to 
confer surfaces of high resistance to nonspecific protein adsorption, bacterial adhesion 
and/or biofilm formation [9]. The biocompatibility of bioceramics is very closely 
related to cell behavior in contact with them and particularly to cell adhesion to their 
surface. The surface characteristics of these materials as their topography, chemistry or 
surface energy, play an essential role in their biocompatibility [2]. It is important to 
remark that depending of the bioceramic functionality the specific requirements in terms 
of cells/proteins adhesion are completely different. Thus, for bone tissue regeneration 
purposes tailoring the surfaces of implants to actively promote bone bonding while 
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avoiding bacterial colonization represents an interesting challenge to achieve better 
clinical results. This phenomenon can be achieved through a double approach: the 
antibacterial properties of the implant surface itself and the capability to promote 
eukaryotic cell integration, i.e. the “race for the surface” theory. This concept, which 
was introduced in 1987 by the orthopedic surgeon Gristina [10], contemplates a race 
between eukaryotic cells and bacteria for the biomaterial surface. Thus, the real goal is 
to design implant surfaces that make the race being won by eukaryotic cells. This would 
allow the biomaterial surface to be covered by cell tissue, which will make it less 
susceptible to bacterial colonization.  However, these requirements are totally different 
for NPs as drug nanocarriers or contrast agents in nanomedicine, since the major 
problem is their opsonization and scavenging by the mononuclear phagocytic system 
(MPS), which demands non-fouling surfaces able to totally inhibit serum protein 
adhesion.  
Basically, the way eukaryotic cells interact with a surface is through an interface which 
consists of discrete attachment points denoted as integrins (see Figure 1A). These 
integrins interact with specific moeties of the extracellular matrix, such as RGD motifs 
[11].  In this sense, the surface chemistry at the nanoscale can be a deciding factor in 
which type of integrin will mediate cell adsorption onto the biomaterial surface [12]. On 
the contrary, bacteria are prokaryotic cells and differ from eukaryotic cells in two main 
aspects [13]: i) their cell wall is composed of phospholipids, like eukaryotic cells, but 
they are much more rigid due to an external layer of peptidoglycan, and ii) they are 
much smaller in size than eukaryotic cells (see schematic depiction in Figure 1A). It has 
been demonstrated that both features of bacteria, smaller size and stiffness than 
eukaryotic cells, might be key factors accounting for their capability to perceive 
variations in the chemical and topological features of biomaterial surfaces at the 
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nanoscale [2]. In terms of surface adhesion, whereas single eukaryotic cells can adhere 
to surfaces independently of each other through integrins, bacteria live on surfaces as a 
community within a resistant-extracellular polymeric substance, denoted as bacteria 
biofilm. The first step of biofilm formation, i.e. adhesion, is governed primarily by the 
electrostatic attraction forces between bacteria and surfaces (mediated by adhesins) and 
where the electrochemical nature of the bioceramic plays a major role [14,15]. 
Therefore, zwitterionic surfaces are capable of forming a hydration layer that would act 
as barrier to hinder bacterial adhesion, which would allow preventing infection in the 
bioceramic. In fact, recently, opposite behavior against bacterial and osteoblast cells in 
different bioceramics with zwitterionic nature has been described [16,17]. These results 
demonstrate that bioceramics could be specifically designed to promote osteoblast 
function while reducing bacterial colonization, which would be particularly pertinent for 
the successfully fabrication of bone implants. Similar results have been also described 
for nanostructured surfaces of Ti6Al4V implants [18]. However, the mechanisms 
regulating the bacterial and cells response to nanostructured surfaces have not been fully 
elucidated, although they seem to be mainly based on the smaller size and stiffness of 
the bacteria able to sense entities in the nanoscale [19].  
On the other hand, regarding NPs for application in nanomedicine, when NPs contact 
physiological fluids they are prone to experience non-specific adsorption of biological 
molecules, mainly plasma serum proteins, which creates a dynamic “protein corona” 
(opsonization) that makes difficult to foresee and/or regulate their in vivo behavior 
(Figure 1B) [20,21]. In fact, formation of “protein corona” followed by recognition and 
engulfing by the cells of the MPS is a common final destination of many NPs, which are 
rapidly cleared from the bloodstream [22,23]. Thus, for such applications it is essential 
to avoid the serum protein adhesion by designing nonfouling surfaces with “stealth” 
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properties during their path in the bloodstream to reach the target cell and/or tissue and 
to exert the desired functionality.  
 
3. Chemical Strategies for the Zwitterionization of Bioceramics  
3.1. Functionalization with Low-Molecular Weight Zwitterionic Moieties 
It is possible to functionalize the surface of bioceramics by grafting low-molecular 
weight zwitterionic moieties. This strategy offers several advantages compared to those 
involving zwitterionic polymers, because it usually involves more simple and “user-
friendly” methods and, in the case of NPs, this method does not increase their 
hydrodynamic size. Herein we summarize the recent approaches to graft amino acids, 
sulfobetaine (SB) derivatives, or alkoxysilanes, onto the surface of bioceramics. 
3.1.1. Amino Acids 
Amino acids are good alternatives to provide bioceramics of zwitterionic nature. For 
instance, cysteine (Cys), which is a low cost and widely available amino acid, was 
grafted to the surface of silica NPs via a two-step procedure [24]. In a first step the 
surface silanol groups of silica NPs were reacted with an epoxide-containing 
alkoxysilane in an acidic water/ethanol mixture. Then, a coupling reaction between 
epoxide surface groups and free sulfhydryl group of Cys was carried out under basic pH 
conditions, yielding a thioether linkage (structure 1, Figure 2).  
3.1.2. Sulfobetaine Derivatives 
Schlenoff and co-workers reported the grafting of the highly water-soluble SB siloxane 
(SBS), to the surface of silica NPs (structure 2, Figure 2) [25,26].
 
In a first step they 
synthetized and isolated SBS by ring opening addition of propane sultone by an 
aminoalkylsiloxane. Then, SBS was added to the silica NPs in different amounts to 
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determine the minimum surface coverage needed to confer stability on the particles in 
salt and protein media. The same authors reported the functionalization of 
superparamagnetic iron oxide (Fe2O3) NPs (SPIONPs) by using SBS  
by either in situ or post-synthesis zwitterionization (structure 2, Figure 2) [27]. 
On the other hand, dopamine (DOPA) has been reported to have a high affinity for 
IONPs due to strong chelation of the catechol unit to the iron centers. This has been 
exploited to develop 10 nm-sized zwitterionic SPIONPs sing a compact DOPA 
sulfonate ligand (structure 3, Figure 2) [28-30]. 
3.1.3. Mixtures of Alkoxysilanes  
It is also possible to exploit silanes chemistry to graft alkoxysilanes bearing charged 
organic groups onto the surface of hydroxyl(–OH)-containing bioceramics. There are 
two main strategies, the co-condensation and the post-synthesis method. Co-
condensation route, which has been used during the synthesis of silica-based 
mesoporous materials (SMMs), involves the addition of alkoxysilanes together with the 
silica precursor (typically tetraethylorthosilicate, TEOS) during the synthesis step. Thus, 
SBA-15-type mesoporous silica bearing –NH3

/–COOΘ groups was prepared by using 
stoichiometric amounts of 3-aminopropyltrimethoxysilane (APTES) and carboxyethyl 
silanetriol sodium salt (CES) organosilanes as ammonium and carboxylate sources, 
respectively, during the synthesis (structure 4, Figure 4) [16,31]. Following this 
strategy, zwitterionic SBA-15 was also prepared by using an alkoxysilane containing 
primary and secondary amine groups (N-(2-aminoethyl)-3-aminopropyl-
trimethoxysilane) (DAMO) (structure 5, Figure 2) [32]. The zwitterionic nature of this 
material comes from the –NH3

/–SiOΘ and >NH2

/–SiOΘ zwitterionic pairs present 
onto the material surface. 
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The post-synthesis method consists in covalently grafting suitable organosilanes to 
the –OH groups of as-synthesized bioceramics. Accordingly, the P–OH groups present 
in the surface of hydroxyapatite (HA) were reacted under anhydrous conditions with a 
mixture of APTES and CES, used as –NH3

 and –COOΘ sources, respectively 
(structure 4, Figure 4) [17].  
3.2. Functionalization with Zwitterionic Polymers 
Zwitterionic polymers, with mixed positively and negatively charged moieties within 
the same polymer chain and overall charge neutrality, have been widely used to design 
ultralow fouling surfaces able to resist nonspecific protein adsorption, bacterial 
adhesion and biofilm formation [33-37].
 
The most widely used method to graft 
zwitterionic polymers to bioceramic surfaces is the surface-initiated atom transfer 
radical polymerization (SI-ATRP) [38]. This method has been used to coat silica NPs 
with poly(sulfobetaine) (pSB) (structure 6, Figure 2) [39] and polycarboxybetaine 
(pCB) derivatives [40,41]. Alternatively, surface reversible addition-fragmentation 
chain transfer (RAFT) polymerization has been used to graft SB copolymers from 
mesoporous silica nanoparticles (MSNPs) [42]. Although “graft-from-surface” methods 
have been widely exploited, they require multistep synthetic procedures and very 
careful conditions which limit its practical application. To address this problem, another 
strategy, the “graft-to-surface” method has been developed. In this method, polymers 
carrying adhesive moieties with strong surface affinity are synthesized and then grafted 
onto the surface through their adhesive moieties. Using this approach, IONPs were 
coated with pCB derivatives via two 3,4-dihydroxyphenyl-L-alanine-DOPA surface 
adhesive groups (structure 7, Figure 2) [43]. More recently, Xiao et al. have developed 
an easy route to introduce zwitterionic nature to poly(acrylic acid) (pAA)-coated IONPs 
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by using EDC/NHS chemistry to couple 3-(diethylamino)propylamine (DEAPA) to a 
significant fraction of the surface carboxyl groups (structure 8, Figure 2) [44]. 
 
4. Methods for the Characterization of Zwitterionic Materials 
Chemical characterization of zwitterionic biceramics is crucial to predict and understand 
the performance of these materials in biological milieu. For this purpose, the different 
characterization techniques must fulfill some requirements such as i) getting 
information about the physicochemical nature of the surface at the nanoscale and/or 
atomic level; ii) identifying and quantifying  the zwitterionic pairs onto the bioceramic 
surface; iii) revealing the chemical bonds that maintain organic functions linked to the 
bioceramic surface; iv) determining the homogeneity degree regarding zwitterionic 
moieties distribution onto the materials surface; and v) predicting the ionization status 
of zwitterionic pairs at physiological conditions depending on the surface 
electrochemistry of these matrices. There are a number of techniques that satisfy some 
of these conditions, such as Fourier transform infrared spectroscopy (FTIR), Scanning 
transmission electron microscopy (STEM) and energy dispersive X-ray spectroscopy 
(EDS), X-ray photoelectron spectroscopy (XPS), solid-state nuclear magnetic resonance 
(NMR) spectroscopy and zeta()-potential (Figure 3), but is their overall combination 
which give complete information about zwitterionic bioceramics.   
4.1. Fourier Transform Infrared Spectroscopy 
FTIR is a powerful qualitative tool to identify the presence of functional groups either 
charged or neutral, (e.g. –NH3

/NH2 and COO
Θ/COOH pairs), which allows 
determining the zwitterionic nature of a bioceramic [17,24,31,32]. Figure 3 shows FTIR 
spectra corresponding to pure silica SBA-15 and zwitter-SBA15
 
materials, chosen as 
representative examples (structure 4, Figure 2) [31]. FTIR spectrum of zwitter-SBA15 
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sample displays bands at 3344 and 1500 cm
-1
 corresponding to the NH stretching and 
deformation frequencies, and bands at 3100 and 590 cm
-1
 corresponding to –NH3

 
stretching and deformation frequencies, respectively. On the other hand, FTIR spectrum 
also shows bands at 1620 and 1400 cm
-1
 of the anti-symmetric and symmetric 
frequencies of COO
Θ
 and a band at 1720 cm
-1 
of COOH group. Hence, the presence of –
NH3

/ COO
Θ
 pairs is shown, confirming the zwitterionic nature of this bioceramic.  
4.2. Scanning Transmission Electron Microscopy  
STEM technique give information related to the overall distribution of the functional 
groups into the bioceramic surface. This is very important to determine the degree of 
homogeneity of the zwitterionization process throughout the sample. For instance, EDS 
coupled to STEM was used to study zwitter-SBA15 mesoporous crystals (structure 5, 
Figure 2) [32]. The aim was investigating the distribution of the functional groups into 
the mesoporous crystals. EDS study was carried out by selecting different mesoporous 
crystals and recording N, O and Si maps. Mapping of the square region highlighted in 
the STEM image (Figure 3) showed a very weak N signal, suggesting that N from 
DAMO were randomly and homogeneously distributed within the silica framework.  
4.3. X-ray Photoelectron Spectroscopy 
XPS is a powerful technique to characterize zwitterionic surfaces due to its capability to 
identify the surface groups, the chemical state of the atoms, and the relative abundance 
in the different surfaces with high rate of sensibility [31,45,46]. For instance, XPS has 
been used to characterize zwitter-SBA15 bioceramic (structure 4, Figure 2) [31]. Bare 
SBA-15 and zwitter-SBA15 showed binding energies of O1s and Si2p core-levels at 
532.9 and 103.4 eV, respectively, which are characteristic of silica-based materials. In 
the case of zwitter-SBA15 sample the C1s line profile was fitted to three components at 
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284.9, 286.8, and 288.6 eV (Figure 3). The component at 284.9 eV is associated with 
CC/CH bonds of the alkyl chains of APTES; the component at 286.6 eV can be 
attributed to C-O moieties of remaining surfactant; and finally at the component located 
at 288.6, which represents 10% of the total area of the peaks, is characteristic of COO 
functional groups. The high resolution N1s line profile was rather asymmetrical 
displaying broadening in the high binding energy side, suggesting that more than one 
component was present. In fact, the N1s peak was satisfactorily fitted to two 
components at binding energies of 400.9 and 402.9 eV, which are usually assigned to -
NH2 and –NH3
 
moieties, respectively (Figure 3). Moreover, from peak areas and 
atomic sensitivity factors it was possible to quantitatively evaluate the species present 
onto the bioceramic surface.  
4.4. Solid-State Nuclear Magnetic Resonance Spectroscopy 
Solid state NMR spectroscopy is a powerful technique to assess the chemical grafting of 
organic groups containing zwitterionic moieties to the surface of bioceramics bearing –
OH groups, such as –SiOH and –POH by using 29Si NMR and 31P NMR probes, 
respectively. For example, 
29
Si solid state NMR was used to study the nature of the 
chemical bonds between organic functions and silica matrix in zwitter-SBA15 
bioceramic (structure 4, Figure 2) [31]. These studies revealed the appearance of signals 
attributable to T
n
 units [R-Si(OSi)n- (OX)3-n] (X = H,C) of the organosilane groups 
grafted onto the silica matrix. The highest relative abundance corresponded to Si atoms 
in T
3
 environments [R-Si(OSi)3] (signal at ca. -70 ppm), which confirmed the existence 
of covalent linkages between the silica surface and the organic groups (Figure 3).  
In another example, 
31
P NMR spectroscopy was used to characterize the covalent 
grafting of organosilanes (APTES and CES) onto the surface of HA [17]. 
31
P NMR 
spectra of both HA and zwitter-HA displayed a narrow resonance at 1.8 ppm (q
0
) 
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assigned to orthophosphate tetrahedron [PO4] species characteristic of HA (Figure 3). 
However, 
31
P NMR spectrum of zwitter-HA exhibited an additional weak signal at ca. 8 
ppm, which fall within the range typically found for 
31
P in q
1
 tetrahedra. This finding 
evidenced the formation of P–O–Si bonds and confirmed the successful silylation of 
HA surface by using suitable alkoxysilanes.  
Finally, it is well-known that solid state 
13
C NMR spectroscopy can be also used to 
confirm the efficient surface functionalization of bioceramics (data not shown).  
Zeta -potential 
When zwitterionic bioceramics are intended for given biomedical applications it is 
essential to determine the pH values where the zwitterionic nature of these bioceramics 
is preserved. For this purpose, the isoelectric point (IEP) of samples in aqueous media, 
which match the zero charge point, is usually determined. Thus, potential 
measurements of bioceramic suspensions in aqueous medium at different pH values are 
recorded. Figure 3 displays, as a representative example, -potential vs pH plots for 
SBA-15 and zwitter-SBA15 (structure 5, Figure 2) (Figure 3) [32]. The graph clearly 
reveals the preservation of the zwitterionic nature of zwitter-SBA15 at the physiological 
pH of 7.4 (-potential = 0), which accounts for the potential biomedical application of 
this bioceramic. 
 
5. Potential Biomedical Applications of Zwitterionic Ceramics 
This section focuses on zwitterionic bioceramics with potential biomedical applications 
in local drug delivery, bone tissue regeneration and nanomedicine. Table 1 summarizes 
the different bioceramics reported to date, the type of functionalization used to provide 
them of zwitterionic nature, their non-fouling and/or antibacterial properties, their 
development phase and their potential biomedical applications. 
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5.1. Local Drug Delivery 
The treatment of bone diseases by local drug delivery from implantable bioceramics has 
several advantages compared to systemic administration, such as minimized side effects 
and risk of overdose, as well as improved bioavailability and effective drug 
concentrations at the target site [1]. Among bioceramics SMMs have been widely 
explored as local drug delivery systems [47-50]. These matrices exhibit excellent 
properties, such as high surface areas and pore volumes, tunable and narrow pore size 
distributions and easily functionalizable surfaces, which make them ideal matrices to 
host diverse biologically active molecules [51]. The relatively easy functionalization of 
their surface permits SMMs being submitted to optimized zwitterionization procedures, 
which represents an added value for their potential biomedical applications. Figure 4 
displays an example of a SBA-15 type mesoporous bioceramic bearing –NH3

/–SiOΘ 
and >NH2

/–SiOΘ pairs [32] (structure 5, Figure 2), whose zwitterionic nature was 
preserved at pH 7.4. In vitro bacterial adhesion assays indicated a 99.9% reduction in S. 
aureus bacterial adhesion in zwitter-SBA15 compared to pristine SBA-15. In this case 
the bacterial adhesion was determined both qualitatively and quantitatively, by confocal 
microscopy studies and the counting of colony forming units (CFUs) [52], respectively. 
Moreover, zwitter-SBA15 was capable to host antibiotics and release them in a 
sustained fashion. Thus, in vitro loading and release assays using cephalexin as a model 
antibiotic proved that zwitter-SBA15 can host ca. 13 mg g
-1
 of drug and release for 
more than 15 days. This dual role, antibacterial adhesion and antibiotic drug delivery, 
constitutes a step forward for development of advanced bioceramics for the 
management of bone implant infection.  
When aimed at developing implantable bioceramics it would be desirable to attain 
surfaces able to inhibit bacterial colonization whereas permitting the adhesion of tissue 
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cells. Thus, our research group developed a zwitterionic SBA-15 containing –NH3

/–
COO
Θ 
surface moieties (Figure 5.A) [31]
 
(structure 4, Figure 2). This zwitter-SBA15 
exhibited zwitterionic nature at pH values ca. 5.5, whereas the surface was negatively 
charged at the physiological pH of 7.4 (Figure 5.A). The ability of zwitter-SBA15 to 
inhibit E. coli adhesion was in vitro evaluated at pH 5.5, which is representative of 
severe inflammation/infection conditions [16]. The obtained results indicated that 
zwitter-SBA15 reduced bacterial adhesion ca. 93% relative to bare SBA-15 (Figure 
5.B), as derived from the counting of CFUs. Nonetheless further studies are needed with 
other pathogens, such as S. aureus or S. epidermidis to better define the antibacterial 
properties of these materials.  In addition, in vitro tests with human Saos-2 osteoblasts 
cultures allowed investigating the cell response onto zwitter-SBA15 at the physiological 
pH of 7.4. The results showed that zwitter-SBA15 exhibited good biocompatibility, 
with Saos-2 osteoblasts adhering, proliferating and preserving their morphological and 
functional features (Figure 5.C) [16].
  
5.2. Bone Tissue Regeneration 
The recent progresses in the design of advanced bioceramics with tailored surface 
properties open promising insights in the development of novel biocompatible implants 
with antibacterial adhesion for bone tissue regeneration. In this sense HA is one of the 
bioceramics more widely exploited in clinic [53]. HA is a calcium phosphate-based 
widely used in many areas of dental and orthopedic reconstructive medicine due to its 
similarity with natural bone, biocompatibility, bioactivity and osteoconductivity 
[53,54].
 
HA is commercially available in several physical forms, including powders, 
particles, granules, dense blocks, cements, porous three-dimensional (3D) scaffolds, 
implant coatings and composite components. Providing HA of antibacterial adhesion 
capability would add an interesting property to this bioceramic for potential clinical 
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purposes. Thus, our research group provided the surface of HA of zwitterionic nature by 
incorporating –NH3

 /–COOΘ pairs by post-synthesis functionalization with APTES 
and CES (Figure 6) [17]. In a first approach, the zwitterionization method was 
optimized in HA powders prepared by the controlled crystallization method. -potential 
studies indicated that the zwitterionic nature of zwitter-HA was preserved at the 
physiological pH of 7.4. Then, this methodology was successfully applied to HA shaped 
as 3D-scaffolds prepared by using rapid prototyping. This constitutes a major advance 
in bone tissue regeneration technologies, since it is possible to functionalize 3D-shaped 
macroporous pieces using a reproducible, easy and cost-efficient methodology. In vitro 
E. coli adhesion assays at physiological conditions indicated that zwitter-HA was able 
to reduce bacterial adhesion in a 99% compared to pristine HA (Figure 6), as derived 
from the counting of CFUs. Furthermore, the biocompatibility of zwitter-HA was 
evaluated using HOS osteoblast-like cell cultures. SEM micrographs showed viable and 
well-spread cells, which have preserved their typical osteoblast morphology, exhibiting 
polygonal shapes with small filopodia-like projections anchored to both surfaces 
(Figure 6). Regarding cell morphology, no differences were observed between 
zwitterionic and bare HA samples. The study of the cell colonization of the different 
levels of 3D scaffolds proved that the different scales of porosity, i.e. channels of ca. 
800 µm and macropores at 0.01-600 µm range, allowed good cellular internalization 
with adequate cell anchorage and subsequent cell colonization over the entire surface of 
the scaffolds. 
 
5.3. Nanomedicine 
Nanoparticles (NPs) usually refer, but are not limited, to particles  100 nm in diameter.  
They exhibit physical and chemical characteristics different from those of bulk 
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materials, opening many possibilities to solve different problems especially in the 
nanomedicine arena [55-58].
 
There are two main reasons that support this fact: i) the 
intrinsic features of NPs can be appropriately exploited for therapy and/or diagnosis 
purposes; and ii) the NPs surface can be functionalized with a great variety of species to 
incorporate targeting ligands, modulate drug adsorption and pharmacokinetics and/or to 
permit extra ways of therapy and/or detection. Inorganic NPs exhibit noteworthy 
advantages compared to their organic counterparts, such as higher thermal, chemical 
and mechanical stabilities under physiological conditions. They also show good 
biocompatibility and relatively low degradation rates. Herein we focus on ceramic NPs, 
highlighting silica NPs and SPIONPs, whose synthesis, features and biomedical 
applications have been extensively overviewed [59-64]. SPIONPs have potential 
application in magnetic resonance image (MRI), hyperthermia treatment and even iron 
deficient anemia in adults. Whatever the application, the size, shape and surface 
properties of NPs have enormous effect on their biodistribution and pharmacokinetics in 
vivo [65,66].
 
As above discussed, one of the major limitations that NPs have to face 
once in vivo administered is opsonization, which adds complexity to their design and 
manufacture for biomedical applications. A widely used approach to overcome this 
concern consists in attaching PEG to the surface of NPs [67]. Zwitterionization has 
emerged as a powerful alternative to reduce the rate and degree of nonspecific proteins 
adsorption to the NPs surface and therefore inhibiting the formation of a “protein 
corona”. In this section we overview some biomedical applications of zwitterionic 
ceramic NPs.  
5.3.1. Zwitterionic Silica Nanoparticles 
Silica-based NPs have been widely proposed for application in nanomedicine [60,68]. 
Pure silica NPs can be acquired from commercial homes, whereas those incorporating 
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fluorescent dyes, chemotherapeutic agents and targeting ligands can be prepared in the 
lab. It is worth of mention the possibility to functionalize the silica surface with diverse 
organic groups via silane chemistry [69-71]. Silica surfaces are frequently used as the 
outer layer in different core-shell NPs. Their physical chemical properties and 
interaction with biological fluids have been broadly investigated. Their extensive use 
and versatility make silica NPs outstanding model system to develop and evaluate new 
nanoparticle surface chemistry such as zwitterionization.  
Varied zwitterionization strategies have been set up to counter the unspecific protein 
adsorption onto the surface of NPs. Rosen et al. grafted Cys amino acid to LUDOX
TM
 
AS-40 (40% wt colloidal silica in water) [24] (structure 1, Figure 2). Zwitter-NPs 
exhibited excellent stability in both salt and single “sticky” protein solutions of 
lysozyme (Lys, positively charged), bovine serum albumin (BSA, negatively charged), 
and human serum. The surface of Cys-coated particles bears a much smaller charge at 
physiological pH and has the added advantage of being strongly hydrated due to its 
zwitterionic character. These characteristics make the surface largely resistant to fouling 
by serum proteins, which will tend to stick to highly charged surfaces. 
 Estephan et al. linked short-chain zwitterionic SB siloxane (SBS) derivatives 
(structure 2, Figure 2) onto the surface of LUDOX
TM
 AS-40 without evident increase in 
the hydrodynamic size [26,27]. The resulting zwitter-NPs were stable against 
aggregation in 3M NaCl and 50% (v/v) fetal bovine serum (FBS).  
As previously commented, a widely exploited strategy consists in the coating of 
silica NPs with zwitterionic polymers such as pSB, pCB, and pAA derivatives. For 
instance, Dong et al. grafted pSBMA (structure 6, Figure 2) onto silica NPs via SI-
ATRP to attain zwitter-NPs of ca. 120 nm in size and a -potential of -7.5 mV under 
salt-free conditions.[39] The slightly negative surface charge was ascribed to 
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incomplete coverage of the negatively-charged silica surface (structure 6, Figure 2). The 
phase behavior of these zwitter-NPs versus temperature in aqueous solutions and their 
stability in protein phosphate buffer saline (PBS) solutions were evaluated. These NPs 
exhibited and upper critical solution temperature in aqueous solution that can be 
controlled by varying the pSBMA molecular weight, ionic strength, zwitter-NPs 
concentration and solvent polarity. Zwitter-NPs were stable for at least 72 h in both Lys 
and BSA solutions as well as PBS. The adjustable phase behavior and stability in 
protein solutions, combined with the reported biocompatibility and hemocompatibility 
of zwitterionic polymers make these zwitter-NPs good candidates for application in 
biosensing, smart drug delivery, implanted devices and other biotechnologies. Sun et al. 
described the attachment of a zwitterionic pSB derivative (poly(2-(dimethylamino)-co-
3-dimethyl-(metacryloyloxyethyl)ammonium propanesulfonate) to the outermost 
surface of MSNPs by RAFT polymerization, affording MSN-p(DMAEMA-co-
DMAPS) (zwitter-MSNPs) [42]. pDMAPS conferred the nanosystem of 
biocompatibility and pDMAEMA made the polymer shell temperature-responsive. 
Rhodamine B (RhB), chosen as model molecule, was loaded into the pores of zwitter-
MSNPs and dye release was monitored by varying the temperature in saline solution. 
Heating provoked volume contraction of polymer shells, which accelerated drug release. 
Besides, in vitro assays demonstrated that zwitter-MSNs had minimal cytotoxicity on 
HeLa cells at 200 µg mL
-1
. These findings open promising expectations in cancer 
treatment through the combination of thermal and chemotherapy. pCB derivatives have 
been also linked to the surface of silica NPs [40,41]. For instance, Jiang and coworkers 
grafted biocompatible zwitterionic poly[(3-acryloylamino)propyl](2-carboxyethyl)-
dimethylammonium] (pCBAA) to silica NPs via SI-ATRP [41]. Zwitter-NPs exhibiting 
two different polymer thicknesses were stable for at least 72 h in both Lys and BSA 
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protein solutions, evidencing the good capability of pCBAA layers to enhance 
biointerfacial characteristics of silica NPs.  
 
5.3.2. Superparamagnetic Iron Oxide Nanoparticles  
SPIONPs exhibit distinctive features, such as high saturation magnetization, high 
chemical stability and potentially reduced toxicity, which make them attractive contrast 
agents to enhance the in vitro and in vivo magnetic resonance imaging (MRI) [72]. The 
preparation of uniformly sized SPIONPs usually involves the use of organic solvents 
[73], and their modification by ligand exchange is essential to provide NPs of 
hydrophilic properties that allow them being considered for biomedical applications 
[74]. Zwitterionization of SPIONPs has arisen as a powerful tool to improve their 
potential in nanomedicine. Among zwitterionic ligands, SB derivatives have been 
widely exploited to enhance the stability of SPIONPs [28-30,75]. Thus, Stephan et al. 
prepared stable aqueous dispersions of SPIONPs in one step in the presence of a 
zwitterionic SBS derivative as the stabilizing/capping/solubilizing ligand (structure 2, 
Figure 2). The hydrodynamic diameter of the NPs was tailored by setting up the 
concentration of zwitterion siloxane, which eventually yielded monodisperse NPs with 
small enough diameters for renal clearance (<6 nm). Zwitter-NPs were properly 
dispersed and stable in aqueous media in the pH range 6−9, but aggregated at lower pH, 
probably due to the existence of some uncapped pH-sensitive Fe-OH groups on the 
surface of NPs. Nonetheless, zwitter-NPs showed lower magnetization values than non-
zwitterionic-NPs due to amorphous content and spin canting, characteristic for NPs of 
such size. NPs showed minimal non-specific adsorption of proteins, which suggest the 
materials will circulate well in vivo.  
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Bawendi and coworkers developed zwitterionic DOPA sulfonate (ZDS) ligand 
coated SPIONPs (structure 3, Figure 2) for use in various medical applications [28,29] 
ZDS-coated SPIONPs were characterized by small hydrodynamic diameters, low non-
specific protein adsorption, the possibility of specific labeling, and stability with respect 
to time, pH, and salinity. Importantly, ZDS coatings did not reduce superparamagnetism 
or saturation magnetization of as-synthesized hydrophobic SPIONPs. Moreover, ZDS-
coated SPIONPs showed only small non-specific uptake into HeLa cancer cells in vitro 
and low non-specific binding to serum proteins in vivo in mice. Zhou et al. also used 
ZDS to coat 4.8 nm-sized gadolinium-embedded iron oxide (GdIO) NPs to produce T1 
contrast agents with a hydrodynamic size of 5.2 that were stable in PBS and 20% FBS 
[30]. In vivo studies revealed high GdIO NPs accumulation in the kidneys and bladder 
after 10 min of injection, whereas NPs were found in the urine after 4 h of injection, 
indicating that they experience fast clearance via glomerular filtration and excretion 
process. Even so, the half-time life of NPs in the bloodstream (around 50 min) was 
enough to permit their passive accumulation within a subcutaneous ovarian cancer.  
Zwitterionic polymers have been also used to coat SPIONPs. For example, Jiang and 
coworkeers prepared pCBMA-DOPA-coated SPIONPs (structure 7, Figure 2), which 
were stable in salt solution and undiluted human blood serum, and exhibited ultra-low 
uptake by macrophages [43]. PAA-DEAPA-coated SPIONPs were developed by Gu 
and coworkers (structure 8, Figure 2) [44].This strategy provided a near-zero 
potential within the pH range of 7.5-8.5 and good anti-fouling properties, as proved 
by a noticeable improved blood circulation time in mice, implying minimized murine 
macrophage uptake. In vivo tests using MRI evidenced that zwitterionic PAA-DEAPA-
NPs could provide good blood pool image contrast up to 2 h after injection, whereas 
PAA-coated NPs were scarcely detected in the bloodstream after 20 min post-injection. 
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Conclusion 
Zwitterionization constitutes an emerging tool for the design of advanced bioceramics 
for biomedical applications. The possibility to tailor the physicochemical properties of 
bioceramics at the nanoscale to inhibit bacterial and non-specific protein adhesion opens 
up new gates to give solutions to major clinical issues, such as bone implant infection 
and the lack of efficiency of therapy and diagnosis with nanocarriers.  
However there are also some challenges that have to be faced before the entrance of 
zwitterionic bioceramics into advanced development clinical phases. They include the 
preservation of biocompatibility, suitable pharmacokinetics and bone healing capability 
in bioceramics for local drug delivery, bone tissue regeneration and nanomedicine.  We 
are in the beginning of a very exciting scientific journey and much research effort is 
needed before moving from the lab bench to the bedside.  
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Tables 
Table 1. Sumary of different zwitterionic bioceramics, their functionalisation strategies, 
properties, cell in vitro assays and potential biomedical applications. 
Bioceramica Functionalisation 
 
Propertiesb 
        Cell in vitro assaysc 
Potential 
Biomedical 
Applications 
Refs. 
Non-
fouling 
Antibacterial 
SMMs 
 
Structure 4 
 
 
STI  
 
 
E. coli 
 
 
Saos-2 
 Local drug 
delivery 
 
[16,31] 
 
 
Structure 5 
 
 
‒ 
S. aureus 
 
‒ 
 
[32] 
 
 
HA 
 
Structure 4  E. coli HOS 
Bone tissue 
regeneration 
[17] 
Silica NPs 
 
Structure 1 
 
 
 
Lys, 
BSA, 
HS 
 
 
‒ 
 
Nanomedicine 
(drug 
delivery) 
 
 
[24] 
 
 
 
Structure 2 
 
‒ ‒ 
 
[25,26] 
 
 
Structure 6 and 
derivatives 
 
Lys, 
BSA 
HeLa 
 
[39,42] 
 
Structure 7 and 
derivatives 
Lys, 
BSA 
‒ [40,41] 
 
IONPs 
Structure 2 
BSA, 
FBS 
‒ ‒ 
Nanomedicine 
(imaging, 
hyperthermia) 
 
 
[27] 
 
 
Structure 3 
 
 
FBS 
 
 
‒ 
 
HeLa 
** 
Nanomedicine 
(imaging, 
sensing, 
hyperthermia) 
 
[28-30] 
 
 
Structure 6 
 
BSA ‒ ‒ 
Nanomedicine 
(imaging) 
[75] 
 
Structure 7 
 
 
HBS 
 
 
‒ 
 
HeLa 
 RAW 264.7 
HUVEC 
 
Nanomedicine 
(imaging) 
 
[43] 
 
 
Structure 8 
 
HS ‒ 
 
RAW 264.7 
*** 
Nanomedicine 
(imaging) 
 
[44] 
 
a 
SMMs: Silica-Based Mesoporous Materials; HA: hydroxyapatite; Silica NPs: Silica Nanoparticles; 
IONPs: Iron Oxide Nanoparticles. 
b
 STI: Soybean Trypsin Inhibitor; Lys: Lysozime; BSA: Bovine Serum Albumin; HS: Human Serum, 
HBS: Human Blood Serum. 
c
 Saos-2: Human osteosarcoma cell line; HOS: Human osteosarcoma cell line; HeLa: Human epitheloid 
cervix carcinoma cell line; HUVEC: Human umbilical vein endothelial cells; RAW 264.7: mouse 
macrophague cell line; (**) In vivo assays in mice have been also performed; (***) In vivo assays in 
rabbits have been also performed. 
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Figures 
 
Figure 1. A) Cell and bacteria interaction into bioceramics for drug delivery systems 
and bone tissue regeneration. The scheme shows the eukaryotic cells interact with a 
bioceramic surfaces through of discrete attachment points (integrins). On the contrary 
the scheme also schematizes bacteria with smaller size and stiffness compared to 
eukaryotic cell, showing the main interaction based on electrostatic attraction forces 
between bacteria and bioceramic surfaces. B) Schematic representation of zwitterionic-
coated nanoparticle and its resistance to non-specific protein adsortion.  
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Figure 2. Chemical strategies for the zwitterionization of bioceramics. A) Grafting of 
low-weight zwitterionic moieties: 1 Cysteine derivatives; 2 Sulfobetaine siloxane 
derivatives; 3 Dopamine sulfonate ligands; 4 3-aminopropyltrimethoxysilane (APTES) 
and carboxyethylsilanetriol sodium salt (CES); 5 (N-(2-aminoethyl)-3-aminopropyl-
trimethoxysilane) (DAMO). B) Grafting of zwitterionic polymers: 6 Poly(sulfobetaine 
methacrylate) (pSBMA);  7 Poly(carboxybetaine methacrylate) (pCBMA) bearing 3,4-
dihydroxyphenyl-1-alanine (DOPA) moieties; 8 3-(diethylamino)propylamine 
(DEAPA) coupled to poly(acrylic acid) (PAA). 
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Figure 3. Schematic representation of the main techniques used for the characterization 
of zwitterionic bioceramic surfaces.  
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Figure 4. SBA-15 structures as local drug delivery systems. Schematic depiction of 
pure silica SBA-15 and zwitterionic SBA-15 prepared following the co-condensation 
route in the presence of N-(2-aminoethyl)-3-aminopropyl-trimethoxysilane (DAMO) 
(SBA15-Zwitter). Counting of colony forming units of S. aureus after 90 of culture onto 
SBA-15 and SBA15-Zwitter surfaces. Statistical significance: *p <0.01. Confocal 
fluorescence micrographs of adhered S. aureus onto SBA-15 and SBA15-Zwitter 
surfaces after staining with Baclight® Kit
TM 
[32].  
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Figure 5. A) Schematic representation of SBA-15 mesoporous bioceramic before and 
after bifunctionalization by co-condensation route with APTES and CES organosilanes 
moeties (structure 4, Figure 2). -potential measurements showing  that zwitter-SBA15 
exhibit s zwitterionic nanture at pH values of 5.5, whereas the surfaces is negatively 
charged at pH values of 7.4 (physiological condictions). B) In vitro E.coli adhesion 
assays after 90 min of incubation indicating a notable reduce of bacteria adhesion in 
zwitter-SBA15 surfaces at pH 5.5. SEM micrographs showing in details the bacteria 
attached to the surfaces of pristine SBA-15 surface and the absence of bacteria onto 
zwitter-SBA15. C) In vitro osteoblast culture assays in physiological condition, 
showing in detail similar osteoblast cell spreading onto both surfaces [16].  
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Figure 6. Schematic representation of the surface of hydroxyapatite (HA) 3D scaffolds, 
before (HA) and after postsynthesis zwitterionization with 3-
aminopropyltrimethoxysilane (APTES) and carboxyethylsilanetriol sodium salt (CES) 
(HA-Zwitter). E. coli adhesion attachment to HA and HA-Zwitter surfaces. Statistical 
significance: *p <0.01. SEM micrographs at 200 x and 1000 x magnifications of the 
surfaces of HA and HA-Zwitter scaffolds after 24 hours of cells spreading assays with 
HOS osteoblast culture [17].  
 
 
 
 
 
 
 
 
*Graphical Abstract
Zwitterionic bioceramics are receiving growing attention by the biomaterials scientific 
community due to their great potential in bone tissue regeneration, local drug delivery 
and nanomedicines. Herein, the different strategies developed so far to synthetize and 
characterize zwitterionic bioceramics with potential clinical applications are 
summarized. 
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